ICD-10-PCS › 3
ICD-10-PCS codes starting with 3
1,516 codes, page 4 of 16. Every code ever valid for billing is listed, including those now retired.
| Code | Description | Status |
|---|---|---|
| 30263P1 | Transfusion of Nonautologous Frozen Red Cells into Central Artery, Percutaneous Approach through FY2019 | Retired |
| 30263Q0 | Transfusion of Autologous White Cells into Central Artery, Percutaneous Approach through FY2019 | Retired |
| 30263Q1 | Transfusion of Nonautologous White Cells into Central Artery, Percutaneous Approach through FY2019 | Retired |
| 30263R0 | Transfusion of Autologous Platelets into Central Artery, Percutaneous Approach through FY2019 | Retired |
| 30263R1 | Transfusion of Nonautologous Platelets into Central Artery, Percutaneous Approach through FY2019 | Retired |
| 30263S0 | Transfusion of Autologous Globulin into Central Artery, Percutaneous Approach through FY2019 | Retired |
| 30263S1 | Transfusion of Nonautologous Globulin into Central Artery, Percutaneous Approach through FY2019 | Retired |
| 30263T0 | Transfusion of Autologous Fibrinogen into Central Artery, Percutaneous Approach through FY2019 | Retired |
| 30263T1 | Transfusion of Nonautologous Fibrinogen into Central Artery, Percutaneous Approach through FY2019 | Retired |
| 30263V0 | Transfusion of Autologous Antihemophilic Factors into Central Artery, Percutaneous Approach through FY2019 | Retired |
| 30263V1 | Transfusion of Nonautologous Antihemophilic Factors into Central Artery, Percutaneous Approach through FY2019 | Retired |
| 30263W0 | Transfusion of Autologous Factor IX into Central Artery, Percutaneous Approach through FY2019 | Retired |
| 30263W1 | Transfusion of Nonautologous Factor IX into Central Artery, Percutaneous Approach through FY2019 | Retired |
| 30263X0 | Transfusion of Autologous Cord Blood Stem Cells into Central Artery, Percutaneous Approach through FY2019 | Retired |
| 30263X1 | Transfusion of Nonautologous Cord Blood Stem Cells into Central Artery, Percutaneous Approach through FY2019 | Retired |
| 30263Y0 | Transfusion of Autologous Hematopoietic Stem Cells into Central Artery, Percutaneous Approach through FY2019 | Retired |
| 30263Y1 | Transfusion of Nonautologous Hematopoietic Stem Cells into Central Artery, Percutaneous Approach through FY2019 | Retired |
| 30273H1 | Transfusion of Nonautologous Whole Blood into Products of Conception, Circulatory, Percutaneous Approach | Valid |
| 30273J1 | Transfusion of Nonautologous Serum Albumin into Products of Conception, Circulatory, Percutaneous Approach | Valid |
| 30273K1 | Transfusion of Nonautologous Frozen Plasma into Products of Conception, Circulatory, Percutaneous Approach | Valid |
| 30273L1 | Transfusion of Nonautologous Fresh Plasma into Products of Conception, Circulatory, Percutaneous Approach | Valid |
| 30273M1 | Transfusion of Nonautologous Plasma Cryoprecipitate into Products of Conception, Circulatory, Percutaneous Approach | Valid |
| 30273N1 | Transfusion of Nonautologous Red Blood Cells into Products of Conception, Circulatory, Percutaneous Approach | Valid |
| 30273P1 | Transfusion of Nonautologous Frozen Red Cells into Products of Conception, Circulatory, Percutaneous Approach | Valid |
| 30273Q1 | Transfusion of Nonautologous White Cells into Products of Conception, Circulatory, Percutaneous Approach | Valid |
| 30273R1 | Transfusion of Nonautologous Platelets into Products of Conception, Circulatory, Percutaneous Approach | Valid |
| 30273S1 | Transfusion of Nonautologous Globulin into Products of Conception, Circulatory, Percutaneous Approach | Valid |
| 30273T1 | Transfusion of Nonautologous Fibrinogen into Products of Conception, Circulatory, Percutaneous Approach | Valid |
| 30273V1 | Transfusion of Nonautologous Antihemophilic Factors into Products of Conception, Circulatory, Percutaneous Approach | Valid |
| 30273W1 | Transfusion of Nonautologous Factor IX into Products of Conception, Circulatory, Percutaneous Approach | Valid |
| 30277H1 | Transfusion of Nonautologous Whole Blood into Products of Conception, Circulatory, Via Natural or Artificial Opening | Valid |
| 30277J1 | Transfusion of Nonautologous Serum Albumin into Products of Conception, Circulatory, Via Natural or Artificial Opening | Valid |
| 30277K1 | Transfusion of Nonautologous Frozen Plasma into Products of Conception, Circulatory, Via Natural or Artificial Opening | Valid |
| 30277L1 | Transfusion of Nonautologous Fresh Plasma into Products of Conception, Circulatory, Via Natural or Artificial Opening | Valid |
| 30277M1 | Transfusion of Nonautologous Plasma Cryoprecipitate into Products of Conception, Circulatory, Via Natural or Artificial Opening | Valid |
| 30277N1 | Transfusion of Nonautologous Red Blood Cells into Products of Conception, Circulatory, Via Natural or Artificial Opening | Valid |
| 30277P1 | Transfusion of Nonautologous Frozen Red Cells into Products of Conception, Circulatory, Via Natural or Artificial Opening | Valid |
| 30277Q1 | Transfusion of Nonautologous White Cells into Products of Conception, Circulatory, Via Natural or Artificial Opening | Valid |
| 30277R1 | Transfusion of Nonautologous Platelets into Products of Conception, Circulatory, Via Natural or Artificial Opening | Valid |
| 30277S1 | Transfusion of Nonautologous Globulin into Products of Conception, Circulatory, Via Natural or Artificial Opening | Valid |
| 30277T1 | Transfusion of Nonautologous Fibrinogen into Products of Conception, Circulatory, Via Natural or Artificial Opening | Valid |
| 30277V1 | Transfusion of Nonautologous Antihemophilic Factors into Products of Conception, Circulatory, Via Natural or Artificial Opening | Valid |
| 30277W1 | Transfusion of Nonautologous Factor IX into Products of Conception, Circulatory, Via Natural or Artificial Opening | Valid |
| 30280B1 | Transfusion of Nonautologous 4-Factor Prothrombin Complex Concentrate into Vein, Open Approach through FY2021 | Retired |
| 30283B1 | Transfusion of Nonautologous 4-Factor Prothrombin Complex Concentrate into Vein, Percutaneous Approach | Valid |
| 302A3H0 | Transfusion of Autologous Whole Blood into Bone Marrow, Percutaneous Approach | Valid |
| 302A3H1 | Transfusion of Nonautologous Whole Blood into Bone Marrow, Percutaneous Approach | Valid |
| 302A3J0 | Transfusion of Autologous Serum Albumin into Bone Marrow, Percutaneous Approach | Valid |
| 302A3J1 | Transfusion of Nonautologous Serum Albumin into Bone Marrow, Percutaneous Approach | Valid |
| 302A3K0 | Transfusion of Autologous Frozen Plasma into Bone Marrow, Percutaneous Approach | Valid |
| 302A3K1 | Transfusion of Nonautologous Frozen Plasma into Bone Marrow, Percutaneous Approach | Valid |
| 302A3L0 | Transfusion of Autologous Fresh Plasma into Bone Marrow, Percutaneous Approach | Valid |
| 302A3L1 | Transfusion of Nonautologous Fresh Plasma into Bone Marrow, Percutaneous Approach | Valid |
| 302A3N0 | Transfusion of Autologous Red Blood Cells into Bone Marrow, Percutaneous Approach | Valid |
| 302A3N1 | Transfusion of Nonautologous Red Blood Cells into Bone Marrow, Percutaneous Approach | Valid |
| 302A3P0 | Transfusion of Autologous Frozen Red Cells into Bone Marrow, Percutaneous Approach | Valid |
| 302A3P1 | Transfusion of Nonautologous Frozen Red Cells into Bone Marrow, Percutaneous Approach | Valid |
| 302A3R0 | Transfusion of Autologous Platelets into Bone Marrow, Percutaneous Approach | Valid |
| 302A3R1 | Transfusion of Nonautologous Platelets into Bone Marrow, Percutaneous Approach | Valid |
| 3C1 | Administration, Indwelling Device, Irrigation | Not billable |
| 3C1ZX8Z | Irrigation of Indwelling Device using Irrigating Substance, External Approach | Valid |
| 3E0 | Administration, Physiological Systems and Anatomical Regions, Introduction | Not billable |
| 3E00X05 | Introduction of Other Antineoplastic into Skin and Mucous Membranes, External Approach | Valid |
| 3E00X0M | Introduction of Antineoplastic, Monoclonal Antibody, into Skin and Mucous Membranes, External Approach | Valid |
| 3E00X28 | Introduction of Oxazolidinones into Skin and Mucous Membranes, External Approach | Valid |
| 3E00X29 | Introduction of Other Anti-infective into Skin and Mucous Membranes, External Approach | Valid |
| 3E00X3Z | Introduction of Anti-inflammatory into Skin and Mucous Membranes, External Approach | Valid |
| 3E00X4Z | Introduction of Serum, Toxoid and Vaccine into Skin and Mucous Membranes, External Approach | Valid |
| 3E00XBZ | Introduction of Anesthetic Agent into Skin and Mucous Membranes, External Approach | Valid |
| 3E00XGC | Introduction of Other Therapeutic Substance into Skin and Mucous Membranes, External Approach | Valid |
| 3E00XGF | Introduction of Other Enzymatic/Chemical Agent into Skin and Mucous Membranes, External Approach | Valid |
| 3E00XKZ | Introduction of Other Diagnostic Substance into Skin and Mucous Membranes, External Approach | Valid |
| 3E00XMZ | Introduction of Pigment into Skin and Mucous Membranes, External Approach | Valid |
| 3E00XNZ | Introduction of Analgesics, Hypnotics, Sedatives into Skin and Mucous Membranes, External Approach | Valid |
| 3E00XTZ | Introduction of Destructive Agent into Skin and Mucous Membranes, External Approach | Valid |
| 3E0102A | Introduction of Anti-Infective Envelope into Subcutaneous Tissue, Open Approach | Valid |
| 3E01305 | Introduction of Other Antineoplastic into Subcutaneous Tissue, Percutaneous Approach | Valid |
| 3E0130M | Introduction of Antineoplastic, Monoclonal Antibody, into Subcutaneous Tissue, Percutaneous Approach | Valid |
| 3E01328 | Introduction of Oxazolidinones into Subcutaneous Tissue, Percutaneous Approach | Valid |
| 3E01329 | Introduction of Other Anti-infective into Subcutaneous Tissue, Percutaneous Approach | Valid |
| 3E0132A | Introduction of Anti-Infective Envelope into Subcutaneous Tissue, Percutaneous Approach | Valid |
| 3E0133Z | Introduction of Anti-inflammatory into Subcutaneous Tissue, Percutaneous Approach | Valid |
| 3E01340 | Introduction of Influenza Vaccine into Subcutaneous Tissue, Percutaneous Approach | Valid |
| 3E0134Z | Introduction of Serum, Toxoid and Vaccine into Subcutaneous Tissue, Percutaneous Approach | Valid |
| 3E0136Z | Introduction of Nutritional Substance into Subcutaneous Tissue, Percutaneous Approach | Valid |
| 3E0137Z | Introduction of Electrolytic and Water Balance Substance into Subcutaneous Tissue, Percutaneous Approach | Valid |
| 3E013BZ | Introduction of Anesthetic Agent into Subcutaneous Tissue, Percutaneous Approach | Valid |
| 3E013GC | Introduction of Other Therapeutic Substance into Subcutaneous Tissue, Percutaneous Approach | Valid |
| 3E013HZ | Introduction of Radioactive Substance into Subcutaneous Tissue, Percutaneous Approach | Valid |
| 3E013KZ | Introduction of Other Diagnostic Substance into Subcutaneous Tissue, Percutaneous Approach | Valid |
| 3E013NZ | Introduction of Analgesics, Hypnotics, Sedatives into Subcutaneous Tissue, Percutaneous Approach | Valid |
| 3E013TZ | Introduction of Destructive Agent into Subcutaneous Tissue, Percutaneous Approach | Valid |
| 3E013VG | Introduction of Insulin into Subcutaneous Tissue, Percutaneous Approach | Valid |
| 3E013VJ | Introduction of Other Hormone into Subcutaneous Tissue, Percutaneous Approach | Valid |
| 3E01XGF | Introduction of Other Enzymatic/Chemical Agent into Subcutaneous Tissue, External Approach | Valid |
| 3E02305 | Introduction of Other Antineoplastic into Muscle, Percutaneous Approach | Valid |
| 3E0230M | Introduction of Antineoplastic, Monoclonal Antibody, into Muscle, Percutaneous Approach | Valid |
| 3E02328 | Introduction of Oxazolidinones into Muscle, Percutaneous Approach | Valid |
| 3E02329 | Introduction of Other Anti-infective into Muscle, Percutaneous Approach | Valid |
| 3E0233Z | Introduction of Anti-inflammatory into Muscle, Percutaneous Approach | Valid |